NO20070299L - Novel heterocyclic compounds - Google Patents

Novel heterocyclic compounds

Info

Publication number: NO20070299L
Authority: NO; Norway
Prior art keywords: heterocyclic compounds; novel heterocyclic; novel; compounds; heterocyclic
Prior art date: 2004-07-12

Application number

NO20070299A

Other languages

English (en)

Inventor

Braj Bhushan Lohray

Vidya Bhushan Lohray

Brijesh Srivastava

Original Assignee

Cadila Healthcare Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-12

Filing date

2007-01-17

Publication date

2007-03-26

2007-01-17 Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd

2007-03-26 Publication of NO20070299L publication Critical patent/NO20070299L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO20070299A 2004-07-12 2007-01-17 Novel heterocyclic compounds NO20070299L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN745MU2004		2004-07-12
PCT/IN2005/000237 WO2006025069A2 (en)	2004-07-12	2005-07-08	Tricyclic pyrazole derivatives as cannabinoid receptor modulators

Publications (1)

Publication Number	Publication Date
NO20070299L true NO20070299L (no)	2007-03-26

Family

ID=35636669

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20070299A NO20070299L (no)	2004-07-12	2007-01-17	Novel heterocyclic compounds

Country Status (20)

Country	Link
US (2)	US8030345B2 (no)
EP (2)	EP2343302A1 (no)
JP (1)	JP2008505965A (no)
KR (1)	KR20070041717A (no)
CN (1)	CN101014605A (no)
AP (1)	AP2228A (no)
AU (1)	AU2005278781B2 (no)
BR (1)	BRPI0513104A (no)
CA (1)	CA2586011C (no)
EA (1)	EA011307B1 (no)
EC (1)	ECSP077167A (no)
GE (1)	GEP20094682B (no)
IL (1)	IL180637A0 (no)
MX (1)	MX2007000491A (no)
NO (1)	NO20070299L (no)
NZ (2)	NZ580387A (no)
TN (1)	TNSN07006A1 (no)
UA (1)	UA88910C2 (no)
WO (1)	WO2006025069A2 (no)
ZA (1)	ZA200700162B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2586011C (en) *	2004-07-12	2011-07-19	Cadila Healthcare Limited	Tricyclic pyrazole derivatives as cannabinoid receptor modulators
JP5746698B2 (ja)	2009-08-28	2015-07-08	アリーナファーマシューティカルズ，インコーポレイテッド	カンナビノイド受容体モジュレーター
EP3385252B8 (en)	2011-02-25	2022-10-26	Arena Pharmaceuticals, Inc.	Cannabinoid receptor modulators
US9597340B2 (en)	2011-02-25	2017-03-21	Arena Pharmaceuticals, Inc.	Cannabinoid receptor modulators
CA2827057C (en)	2011-02-25	2022-06-07	Arena Pharmaceuticals, Inc.	Crystalline forms and processes for the preparation of condensed azacycles (cannabinoid receptor modulators)
ES2770128T3 (es) *	2015-04-30	2020-06-30	Recordati Ag	Derivados de pirazol tricíclicos condensados útiles para modular los receptores farnesoide x
WO2017123826A1 (en)	2016-01-14	2017-07-20	Beth Israel Deaconess Medical Center, Inc.	Mast-cell modulators and uses thereof
MA48625A (fr)	2017-05-08	2020-03-18	Arena Pharm Inc	Composés et méthodes de traitement de la douleur viscérale
CN111757879A (zh) *	2018-01-29	2020-10-09	卡地拉健康护理有限公司	用作抗菌剂的杂环化合物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3260721A (en) *	1962-04-10	1966-07-12	American Cyanamid Co	Heterocyclic derivatives of yohimbe alkaloids
DK7779A (da) *	1978-01-16	1979-07-17	Sandoz Ag	Fremgangsmaade til fremstilling af pnenicilliner eller cephalosporiner
EP0122952B1 (en)	1983-04-22	1987-10-28	Mitsubishi Rayon Co., Ltd.	Apparatus for measuring gas partial pressure in living body
FR2692575B1 (fr)	1992-06-23	1995-06-30	Sanofi Elf	Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2713225B1 (fr)	1993-12-02	1996-03-01	Sanofi Sa	N-pipéridino-3-pyrazolecarboxamide substitué.
CA2106642C (en) *	1992-10-14	2005-08-16	Peter Bod	Carbazolone derivatives and process for preparing the same
FR2714057B1 (fr)	1993-12-17	1996-03-08	Sanofi Elf	Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
US5547975A (en) *	1994-09-20	1996-08-20	Talley; John J.	Benzopyranopyrazolyl derivatives for the treatment of inflammation
FR2741621B1 (fr)	1995-11-23	1998-02-13	Sanofi Sa	Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2742148B1 (fr)	1995-12-08	1999-10-22	Sanofi Sa	Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2758723B1 (fr)	1997-01-28	1999-04-23	Sanofi Sa	Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments
FR2761266B1 (fr)	1997-03-28	1999-07-02	Sanofi Sa	Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
FR2789079B3 (fr)	1999-02-01	2001-03-02	Sanofi Synthelabo	Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
FR2800372B1 (fr) *	1999-11-03	2001-12-07	Sanofi Synthelabo	Derives tricycliques d'acide 1-benzylpyrazole-3- carboxylique, leur preparation, les medicaments en contenant
FR2800375B1 (fr) *	1999-11-03	2004-07-23	Sanofi Synthelabo	Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
FR2804604B1 (fr)	2000-02-09	2005-05-27	Sanofi Synthelabo	Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac
FR2809621B1 (fr)	2000-05-12	2002-09-06	Sanofi Synthelabo	Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles comme antidiarrheiques
FR2816938B1 (fr)	2000-11-22	2003-01-03	Sanofi Synthelabo	Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant
EP1421077A4 (en)	2001-08-31	2004-11-17	Univ Connecticut	NEW PYRAZOLANALOGS ON CANNABINOID RECEPTORS
ES2272809T3 (es)	2001-09-21	2007-05-01	Solvay Pharm Bv	Nuevos derivados de 4,5-dihidro-1h-pirazol con actividad antagonista de cb1.
TWI231757B (en)	2001-09-21	2005-05-01	Solvay Pharm Bv	1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
AU2002333853B2 (en)	2001-09-21	2006-07-13	Solvay Pharmaceuticals B.V.	4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
US6509367B1 (en)	2001-09-22	2003-01-21	Virginia Commonwealth University	Pyrazole cannabinoid agonist and antagonists
MXPA04008130A (es) *	2002-02-19	2004-11-26	Pharmacia Corp	Derivados triciclicos de pirazol para el tratamiento de la inflamacion.
ITMI20041033A1 (it) *	2004-05-24	2004-08-24	Neuroscienze S C A R L	Composti farmaceutici
CA2586011C (en) *	2004-07-12	2011-07-19	Cadila Healthcare Limited	Tricyclic pyrazole derivatives as cannabinoid receptor modulators

2005
- 2005-07-08 CA CA2586011A patent/CA2586011C/en not_active Expired - Fee Related
- 2005-07-08 GE GEAP20059851A patent/GEP20094682B/en unknown
- 2005-07-08 KR KR1020077000654A patent/KR20070041717A/ko not_active Ceased
- 2005-07-08 UA UAA200700981A patent/UA88910C2/ru unknown
- 2005-07-08 EP EP10182912A patent/EP2343302A1/en not_active Withdrawn
- 2005-07-08 EP EP05815697A patent/EP1781668A2/en not_active Withdrawn
- 2005-07-08 NZ NZ580387A patent/NZ580387A/en not_active IP Right Cessation
- 2005-07-08 JP JP2007520976A patent/JP2008505965A/ja not_active Withdrawn
- 2005-07-08 WO PCT/IN2005/000237 patent/WO2006025069A2/en not_active Ceased
- 2005-07-08 US US11/632,236 patent/US8030345B2/en not_active Expired - Fee Related
- 2005-07-08 EA EA200700246A patent/EA011307B1/ru not_active IP Right Cessation
- 2005-07-08 NZ NZ552670A patent/NZ552670A/en not_active IP Right Cessation
- 2005-07-08 CN CNA200580030114XA patent/CN101014605A/zh active Pending
- 2005-07-08 AU AU2005278781A patent/AU2005278781B2/en not_active Ceased
- 2005-07-08 MX MX2007000491A patent/MX2007000491A/es not_active Application Discontinuation
- 2005-07-08 AP AP2007003880A patent/AP2228A/xx active
- 2005-07-08 BR BRPI0513104-9A patent/BRPI0513104A/pt not_active IP Right Cessation
2007
- 2007-01-05 ZA ZA200700162A patent/ZA200700162B/xx unknown
- 2007-01-10 IL IL180637A patent/IL180637A0/en unknown
- 2007-01-11 TN TNP2007000006A patent/TNSN07006A1/en unknown
- 2007-01-12 EC EC2007007167A patent/ECSP077167A/es unknown
- 2007-01-17 NO NO20070299A patent/NO20070299L/no not_active Application Discontinuation
2010
- 2010-04-29 US US12/769,861 patent/US20100273791A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NZ580387A (en)	2011-06-30
EP2343302A1 (en)	2011-07-13
WO2006025069A2 (en)	2006-03-09
AU2005278781B2 (en)	2009-06-18
US20080051386A1 (en)	2008-02-28
NZ552670A (en)	2010-02-26
CA2586011A1 (en)	2006-03-09
EA200700246A1 (ru)	2007-08-31
JP2008505965A (ja)	2008-02-28
WO2006025069A3 (en)	2006-04-27
MX2007000491A (es)	2007-03-28
IL180637A0 (en)	2007-06-03
US8030345B2 (en)	2011-10-04
AU2005278781A1 (en)	2006-03-09
WO2006025069A8 (en)	2007-03-15
AP2007003880A0 (en)	2007-02-28
GEP20094682B (en)	2009-05-10
KR20070041717A (ko)	2007-04-19
ZA200700162B (en)	2009-09-30
EP1781668A2 (en)	2007-05-09
CA2586011C (en)	2011-07-19
CN101014605A (zh)	2007-08-08
EA011307B1 (ru)	2009-02-27
AP2228A (en)	2011-04-01
BRPI0513104A (pt)	2008-04-29
ECSP077167A (es)	2007-05-30
US20100273791A1 (en)	2010-10-28
UA88910C2 (ru)	2009-12-10
TNSN07006A1 (en)	2008-06-02

Publication	Publication Date	Title
DK1919907T5 (da)	2011-09-12	Heterocyklisk forbindelse
ATE414693T1 (de)	2008-12-15	Neuartige cis-imidazoline
EP1873153A4 (en)	2009-09-30	HETEROCYCLIC CONNECTION
ATE394399T1 (de)	2008-05-15	Tetrahydropyridoindolderivate
ATE540935T1 (de)	2012-01-15	Chinazolinderivate
ATE383361T1 (de)	2008-01-15	Pyrrazolopyrimidinderivate
ATE417830T1 (de)	2009-01-15	Sulfonylbenzimidazolderivate
DE602004019555D1 (de)	2009-04-02	Heterocyclische 7-aminoalkylidenylchinolone und -naphthyridone
DK1937650T3 (da)	2011-10-03	Heterocykliske forbindelser
NO20070299L (no)	2007-03-26	Novel heterocyclic compounds
ATE443056T1 (de)	2009-10-15	Substituierte n-sulfonylaminophenylethyl-2- phenoxyacetamidverbindungen
ITMI20042238A1 (it)	2005-02-19	Composti per fluoropolirterei
ATE404546T1 (de)	2008-08-15	Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen
ATE430142T1 (de)	2009-05-15	Phenylpiperazin-methanon-derivate
DK1812448T3 (da)	2012-08-27	Organiske forbindelser
ATE404542T1 (de)	2008-08-15	4-phenylpyrimidin-2-carbonitrilderivate
ATE365731T1 (de)	2007-07-15	4-amino-5-cyanopyrimidinderivate
DE112005002826A5 (de)	2007-12-27	Ausgleichseinheit
DE602005004472D1 (de)	2008-03-13	Ausgleichsanordnung
SE0402103D0 (sv)	2004-08-30	Novel compounds
ATE384719T1 (de)	2008-02-15	Dioxazinyl-substituierte thienylsulfonylaminocarbonylverbindungen
SE0400022D0 (sv)	2004-01-08	New compounds
SE0400254D0 (sv)	2004-02-06	New compounds
SE0403054D0 (sv)	2004-12-15	Novel compounds
SE0402069D0 (sv)	2004-08-24	Novel compounds

Legal Events

Date	Code	Title	Description
2013-03-11	FC2A	Withdrawal, rejection or dismissal of laid open patent application